HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergistic potentiation of (-)-lomaiviticin A cytotoxicity by the ATR inhibitor VE-821.

Abstract
(-)-Lomaiviticin A (1) is a cytotoxic bacterial metabolite that induces double-strand breaks in DNA. Here we show that the cytotoxicity of (-)-lomaiviticin A (1) is synergistically potentiated in the presence of VE-821 (7), an inhibitor of ataxia telangiectasia and Rad3-related protein (ATR). While 0.5nM 1 or 10μM 7 alone are non-lethal to K562 cells, co-incubation of the two leads to high levels of cell kill (81% and 94% after 24 and 48h, respectively). Mechanistic data indicate that cells treated with 1 and 7 suffer extensive DNA double-strand breaks and apoptosis. These data suggest combinations of 1 and 7 may be a valuable chemotherapeutic strategy.
AuthorsLaureen C Colis, Seth B Herzon
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 26 Issue 13 Pg. 3122-3126 (07 01 2016) ISSN: 1464-3405 [Electronic] England
PMID27177826 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2016 Elsevier Ltd. All rights reserved.
Chemical References
  • 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide
  • Fluorenes
  • Pyrazines
  • Sulfones
  • lomaiviticin A
Topics
  • Apoptosis (drug effects)
  • Cell Survival (drug effects)
  • DNA Breaks, Double-Stranded (drug effects)
  • Dose-Response Relationship, Drug
  • Fluorenes (chemical synthesis, chemistry, pharmacology)
  • Humans
  • K562 Cells
  • Molecular Structure
  • Pyrazines (chemistry, pharmacology)
  • Stereoisomerism
  • Structure-Activity Relationship
  • Sulfones (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: